Diagnostics and radiodiagnostic devices and supplies | Tenderlake

Diagnostics and radiodiagnostic devices and supplies

Contract Value:
EUR 34M - 34M
Notice Type:
Contract Notice
Published Date:
27 December 2023
Closing Date:
31 January 2024
Location(s):
FR FRANCE
FRY RUP FR – RÉGIONS ULTRAPÉRIPHÉRIQUES FRANÇAISES (FR FRANCE)
Description:
Supply of Immuno-Hematology analytical systems, reagents and associated services for QBD laboratories

The public contract resulting from this consultation constitutes a single-contractor framework agreement that sets out all the contractual stipulations, executed by issuing purchase orders, in accordance with Article L.2125-1-1° as well as Articles R.2162-1 to R.2162-6, R.2162-13 and R.2162-14 of the Public Procurement Code. Each Lot of this consultation is concluded with a fixed minimum quantity of analytical system(s) and with a maximum amount valid for the entire period of validity of the framework agreement. The minimum quantity set for each batch is the quantity of analytical system(s). The maximum amount provided for each Lot includes all the services provided for in this contract and detailed in the CCTP. Financial results are in euro(s) (excl. VAT). Lot 1: Minimum quantity of analytical system(s): 12; Maximum amount (excl. VAT): 24 million. Lot 2: Minimum quantity in analytical system(s): 8; Maximum amount (excl. VAT): 10 million

Supply of high-speed analytical systems, reagents and related services for the HFS metropolitan and overseas IHD laboratories

The purpose of this consultation is the supply of immunohaematology automata, reagents and the provision of associated services for the Donation Biological Qualification (Qbd) laboratories of the EFS and the CTSA. In addition, the EFS wishes to acquire the equipment to constitute a basic fleet necessary for the activity of biological qualification of donation in mainland France and in the French overseas departments. As a result, the EFS has the option of renting additional equipment to complete its fleet, respond to regulatory changes or to cope with additional activity (e.g. health alerts). Lot 1 concerns the supply of high-speed analytical systems, reagents and associated services for the IHD laboratories in metropolitan France and the French overseas territoriesThe selected analytical system must imperatively be able to carry out the following immuno-haematological examinations:- rAE- adult ABO grouping (donor)- ABO Rh1 grouping baby (donor)- RH-KEL phenotyping 1- Rhw1 phenotyping (low Du or D research)- screening for anti-a and anti-b Ig immune anti-a and anti-b anti- dilution 1/256- extended phenotyping (Jk1 and Jk2 - fy1 and Fy2 - mns1 and Mns3 and Mns4)- expanded phenotyping (Rh8 - kEL 2,3 and 4 - mns1 and 2 - lU 1 and 2 - lE 1 and 2 - p1)The proposed systems will ideally be able to perform the following examinations (not mandatory):- tDA (Igg, C3d, Control)- rAI screening- rAI identification

Supply of high-speed analytical systems, reagents and related services for the metropolitan IHD laboratories of the EFS

The purpose of this consultation is the supply of immunohaematology automata, reagents and the provision of associated services for the Donation Biological Qualification (Qbd) laboratories of the EFS and the CTSA. In addition, the EFS wishes to acquire the equipment to constitute a basic fleet necessary for the activity of biological qualification of donation in mainland France and in the French overseas departments. As a result, the EFS has the option of renting additional equipment to complete its fleet, respond to regulatory changes or to cope with additional activity (e.g. health alerts). Lot 2 concerns the supply of high-speed analytical systems, reagents and associated services for the metropolitan IHD laboratories of the efsThe proposed analytical systems must imperatively carry out the following immuno-haematological examinations:- rAE- adult ABO grouping (donor)- RH-KEL phenotypingThe proposed systems will ideally be able to perform the following examinations (not mandatory):- ABO Rh1 grouping baby (donor)- Rhw1 phenotyping (research Du or low D)- tDA (Igg, C3d, Control)- rAI screening- rAI identification- screening for anti-a and anti-b Ig immune antibodies at 1/256 dilution- extensive phenotyping (Jk1 and Jk2 - fy1 and Fy2 - mns1 and Mnsc3 and Mnsc4)- expanded phenotyping (Rh8 - kEL 2,3 and 4 - mns1 and 2 - lu1 and 2 - le1 and 2 - p1)

Download full details as .pdf
The Buyer:
etablissement Français du Sang
CPV Code(s):
33124000 - Diagnostics and radiodiagnostic devices and supplies
33124130 - Diagnostic supplies
33696200 - Blood-testing reagents
50421000 - Repair and maintenance services of medical equipment
80530000 - Vocational training services